phase readout
saveNCT04644029: Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)
TERMINATEDupdated 1mo ago
community read0 votes
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis
view source ↗
comments(0)
5-min edit window · permanent after that